Skip to content

Safety and Efficacy of Immages System in Patients Recieving IV Therapy

A Study to Assess the Functionality of Pro-IV's IMMAGES Infusion System in Patients Hospitalized in Bait Balev, Receiving Intravenous Therapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02020811
Acronym
IV
Enrollment
50
Registered
2013-12-25
Start date
2013-11-30
Completion date
2014-04-30
Last updated
2013-12-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacteriemia, CHF, Sepsis

Brief summary

The study will evaluate the functionality of IMMAGES , an intravenous infusion device system, in patients hospitalized in Bait Balev hospital. The study will aim to determine how the IMMAGES system integrates within IV infusion therapy regime and what are the advantages and disadvantages, if any, of using this system within the prescribed setting.

Detailed description

Using the IMMAGES system in patients recieving IV therapy will provide the nursing teams on-line information regarding the infusions and will allow them to monitor and manage the treatments in real-time, providing better and safer care for the patients.

Interventions

DEVICESentinel

Sponsors

Bait Balev Hospital
CollaboratorOTHER
PRo-IV
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria: 1. Patients requiring infusion therapy 2. Patients receiving infusion therapy by gravity flow or by pump 3. patients are scheduled to receive at least once a day an infusion therapy 4. Patients are scheduled to receive an infusion therapy for at least 3 days 5. Adult over age of 18 years 6. Informed consent form signed by patient.

Exclusion criteria

<!-- --> 1. Informed consent form not signed 2. Patients are scheduled to receive less than once a day an infusion therapy 3. patients to receive less than 3 days of infusion therapy 4. patients not hospitalized in a ward that is participating in the study. 5. patients participating in another clinical study or clinical field test 6. Patients require isolation treatment

Design outcomes

Primary

MeasureTime frame
Successful operation of IMMAGES defined by patient receiving the prescribed IV medication using the IMMAGES system , openning of the controller valve including using the smartphone application and the management softwareas long as the patient is reciving the IV prescribed medication, and no longer than 10 days

Secondary

MeasureTime frameDescription
- Detection of medical errors by IMMAGESup to 5 minutes from activating the controller on the IV lineIf there is an error related to administration of wrong drug. to the wrong patient , on the wrong timing - the valve of the controller will not open , and the IV line will stay closed, and the patient will not get the wrong drug.

Countries

Israel

Contacts

Primary ContactGizele Sasson, MD
972-52-4425581
Backup Contactmichal Devir, MD
michal@pro-iv.co.il972-9-8664128

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026